# Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia:

> **NCT07638865** · NA · RECRUITING · sponsor: **G.Gennimatas General Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Benign Prostate Enlargement
- Benign Prostate Hypertrophy(BPH)
- Benign Prostate Obstruction (BPO)

## Interventions

- **DIETARY_SUPPLEMENT:** Oxiblume:CoQ10 (Ralivia) therapy
- **OTHER:** Placebo Pill.

## Key facts

- **NCT ID:** NCT07638865
- **Lead sponsor:** G.Gennimatas General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-08
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638865, "Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia:". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07638865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*